US 10519191
Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
granted A61PA61P1/16
Quick answer
US patent 10519191 (Bile acid analogs as FXR/TGR5 agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/16